Statistics from Altmetric.com
By Adele Waters
Pharmaceutical manufacturers are demonstrating some ‘quite shocking’ practices and it is time for them to change their approach to trading in the UK.
That is the view of Simon Innes, chief executive of CVS.
Speaking at last week’s Animal Health Investment Europe conference in London, he said manufacturers needed to modernise and release sufficient profits for veterinary businesses.
‘We are still experiencing some operating procedures by manufacturers that are quite shocking to say the least and I’ve never seen in any other market. I think in any other market they wouldn’t get away with it.
‘They need to start to deliver an appropriate profit for the vet and my view is that if they don’t, then vets should not use them. They should use someone else.
‘There are manufacturers out there who are behaving …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.